Lexaria Bioscience (LEXX) Short Interest Ratio & Short Volume $2.23 +0.02 (+0.90%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lexaria Bioscience Short Interest DataLexaria Bioscience (LEXX) has a short interest of 298,200 shares, representing 1.84% of the float (the number of shares available for trading by the public). This marks a -12.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.2, indicating that it would take 2.2 days of the average trading volume of 260,102 shares to cover all short positions.Current Short Interest298,200 sharesPrevious Short Interest342,400 sharesChange Vs. Previous Month-12.91%Dollar Volume Sold Short$620,256.00Short Interest Ratio2.2 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares17,453,000 sharesFloat Size16,180,000 sharesShort Percent of Float1.84%Today's Trading Volume96,297 sharesAverage Trading Volume260,102 sharesToday's Volume Vs. Average37% Short Selling Lexaria Bioscience? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLEXX Short Interest Over TimeLEXX Days to Cover Over TimeLEXX Percentage of Float Shorted Over Time Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024298,200 shares $620,256.00 -12.9%1.8%2.2 $2.08 11/15/2024342,400 shares $688,224.00 +23.6%2.1%2.4 $2.01 10/31/2024277,100 shares $595,765.00 +0.5%1.7%1.8 $2.15 10/15/2024275,700 shares $791,259.00 -11.4%1.7%1.7 $2.87 9/30/2024311,100 shares $948,855.00 -2.0%2.1%1.8 $3.05 9/15/2024317,500 shares $1.09 million +31.4%2.2%1.8 $3.43 Get the Latest News and Ratings for LEXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024241,700 shares $945,047.00 +54.5%1.7%1.3 $3.91 8/15/2024156,400 shares $492,660.00 -27.8%1.1%0.7 $3.15 7/31/2024216,500 shares $885,485.00 +36.4%1.5%1 $4.09 7/15/2024158,700 shares $461,817.00 No Change1.1%0.8 $2.91 6/30/2024158,700 shares $441,186.00 +3.7%1.3%0.7 $2.78 6/15/2024153,000 shares $472,770.00 -25.7%1.2%0.6 $3.09 5/31/2024205,900 shares $800,951.00 +30.7%1.7%0.5 $3.89 5/15/2024157,500 shares $485,100.00 -38.8%1.4%0.3 $3.08 4/30/2024257,200 shares $794,748.00 -41.0%2.3%0.5 $3.09 4/15/2024435,600 shares $866,844.00 -11.2%3.7%0.9 $1.99 3/31/2024490,400 shares $1.78 million -35.0%4.3%1.1 $3.63 3/15/2024754,500 shares $2.94 million +13.0%6.5%1.7 $3.90 2/29/2024667,900 shares $2.30 million -2.6%6.4%2.1 $3.45 2/15/2024685,700 shares $1.62 million +15.7%6.6%4 $2.36 1/31/2024592,800 shares $883,272.00 -10.5%6.7%4.5 $1.49 1/15/2024662,400 shares $1.00 million -11.6%7.5%4.8 $1.51 12/31/2023749,200 shares $936,500.00 -3.7%8.6%5.8 $1.25 12/15/2023778,100 shares $988,187.00 +5.9%8.9%6.4 $1.27 11/30/2023734,600 shares $1.10 million +3.2%8.6%6.3 $1.50 11/15/2023712,100 shares $954,214.00 +58.2%8.4%7.2 $1.34 10/31/2023450,000 shares $621,000.00 -2.5%6.2%4.1 $1.38 10/15/2023461,500 shares $422,318.19 +9.1%6.4%5.2 $0.92 9/30/2023422,900 shares $422,857.71 +14.5%5.8%4.9 $1.00 9/15/2023369,200 shares $321,573.20 -14.5%5.6%4.2 $0.87 8/31/2023431,900 shares $453,451.81 +0.2%6.2%4.5 $1.05 8/15/2023431,000 shares $478,410.00 +44.9%5.8%3.5 $1.11 7/31/2023297,500 shares $247,966.25 +3.3%4.0%1.6 $0.83 7/15/2023288,100 shares $238,460.37 +4.5%3.9%1.6 $0.83 6/30/2023275,700 shares $201,343.71 -11.0%3.7%1.8 $0.73 6/15/2023309,800 shares $213,823.96 -9.7%4.2%2.1 $0.69 5/31/2023343,000 shares $254,780.40 +31.9%4.7%2.5 $0.74 5/15/2023260,100 shares $188,520.48 -14.4%3.6%1.9 $0.72 4/30/2023303,800 shares $634,942.00 -4.4%5.7%6.5 $2.09 4/15/2023317,900 shares $693,022.00 -6.1%5.9%15.3 $2.18Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem 3/31/2023338,500 shares $920,720.00 +4.2%6.3%16.1 $2.72 3/15/2023325,000 shares $880,750.00 -0.7%6.7%16 $2.71 2/28/2023327,300 shares $991,719.00 +3.8%6.8%16.6 $3.03 2/15/2023315,200 shares $936,207.04 +5.3%6.5%19.5 $2.97 1/31/2023299,400 shares $961,103.94 +9.5%6.2%19.6 $3.21 1/15/2023273,400 shares $757,318.00 +0.0%5.6%18.1 $2.77 12/30/2022273,300 shares $672,318.00 -2.2%5.1%17.2 $2.46 12/15/2022279,300 shares $779,219.07 -8.5%5.2%14.5 $2.79 11/30/2022305,200 shares $903,392.00 -0.6%5.7%13.4 $2.96 11/15/2022307,100 shares $738,575.50 -5.1%5.8%12.8 $2.41 10/31/2022323,600 shares $715,156.00 +3.2%6.1%8.9 $2.21 10/15/2022313,500 shares $661,485.00 -5.2%5.9%8.1 $2.11 9/30/2022330,600 shares $809,970.00 +1.2%6.2%8 $2.45 9/15/2022326,700 shares $957,231.00 -2.3%6.1%6.2 $2.93 8/31/2022334,400 shares $989,824.00 -0.1%6.2%6.2 $2.96 8/15/2022334,600 shares $1.07 million -0.1%6.2%5.6 $3.20 7/31/2022334,900 shares $904,230.00 +15.9%6.2%5.6 $2.70 7/15/2022288,900 shares $826,254.00 -33.7%5.4%3.9 $2.86 6/30/2022435,900 shares $1.30 million +3.7%8.1%0.5 $2.98 6/15/2022420,400 shares $941,696.00 +15.7%7.8%0.5 $2.24 5/31/2022363,500 shares $745,175.00 +34.1%6.8%0.4 $2.05 5/15/2022271,100 shares $555,755.00 -8.8%5.0%0.3 $2.05 4/30/2022297,300 shares $826,494.00 +14.2%5.5%0.3 $2.78 4/15/2022260,400 shares $997,332.00 -2.1%4.8%0.3 $3.83 3/31/2022266,100 shares $878,130.00 -3.8%5.0%4.6 $3.30 3/15/2022276,700 shares $868,838.00 -5.6%5.1%3.5 $3.14 2/28/2022293,100 shares $1.04 million -12.4%5.5%1 $3.55 2/15/2022334,700 shares $1.31 million -11.8%6.2%1.1 $3.90 1/31/2022379,600 shares $1.52 million +15.5%14.0%1.2 $4.00 1/15/2022328,800 shares $1.52 million -7.1%12.1%1.1 $4.61 12/31/2021353,800 shares $1.43 million -13.8%13.3%1.2 $4.03 12/15/2021410,300 shares $1.84 million +26.8%15.4%1.3 $4.49 11/30/2021323,500 shares $1.71 million -9.0%12.2%1.1 $5.30 11/15/2021355,300 shares $2.29 million -1.9%14.8%2.2 $6.44 10/29/2021362,200 shares $2.24 million -3.2%15.1%2.1 $6.19 10/15/2021374,000 shares $2.56 million +10.3%15.6%1.8 $6.84 9/30/2021339,000 shares $2.12 million -5.5%14.1%0.3 $6.26 9/15/2021358,900 shares $2.23 million +22.4%15.0%0.3 $6.21 8/31/2021293,300 shares $1.82 million -5.2%12.2%0.3 $6.22 8/13/2021309,300 shares $1.70 million No Change12.9%0.3 $5.51 LEXX Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 298,200 shares of LEXX short. 1.84% of Lexaria Bioscience's shares are currently sold short. Learn More on Lexaria Bioscience's current short interest. What is a good short interest ratio for Lexaria Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEXX shares currently have a short interest ratio of 2.0. Learn More on Lexaria Bioscience's short interest ratio. What is a good short interest percentage for Lexaria Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.84% of Lexaria Bioscience's floating shares are currently sold short. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a drop in short interest during the month of November. As of November 30th, there was short interest totaling 298,200 shares, a drop of 12.9% from the previous total of 342,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lexaria Bioscience's float size? Lexaria Bioscience currently has issued a total of 17,453,000 shares. Some of Lexaria Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lexaria Bioscience currently has a public float of 16,180,000 shares. How does Lexaria Bioscience's short interest compare to its competitors? 1.84% of Lexaria Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lexaria Bioscience: Adaptimmune Therapeutics plc (2.63%), Puma Biotechnology, Inc. (8.06%), Instil Bio, Inc. (8.02%), Black Diamond Therapeutics, Inc. (10.83%), Galectin Therapeutics Inc. (13.54%), Elutia Inc. (0.55%), Compugen Ltd. (1.49%), Telomir Pharmaceuticals, Inc. (3.83%), Enanta Pharmaceuticals, Inc. (16.38%), Monopar Therapeutics Inc. (0.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXX is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXX, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Adaptimmune Therapeutics Short Squeeze Puma Biotechnology Short Squeeze Instil Bio Short Squeeze Black Diamond Therapeutics Short Squeeze Galectin Therapeutics Short Squeeze Elutia Short Squeeze Compugen Short Squeeze Telomir Pharmaceuticals Short Squeeze Enanta Pharmaceuticals Short Squeeze Monopar Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
